The effect of the ob=ob mutation on microsomal overt and latent acyl CoA:diacylglycerol acyl transferase activities (DGATs I and II) in liver microsomes of mice was investigated. Overt and latent hepatic DGAT activities for 16-week-old lean Ob=? mice were 0.42 AE 0.14 and 1.57 AE 0.04 mmol=mg=min, respectively. For ob=ob mice DGAT I and II activities were 1.17 AE 0.28 and 3.09 AE 0.78 mmol=mg=min, respectively. The hepatic triacylglycerol (TAG) concentration of 16-week-old mice was increased three-fold in ob=ob mice relative to those in lean controls. The data suggest that the increased rate of hepatic TAG secretion and intracellular accumulation in ob=ob mice is accompanied by parallel increases in the activities of both DGATs.
Introduction
Diacylglycerol acyltransferases catalyse the last and committed step in the synthesis of hepatic triacylglycerol (TAG). In the liver, the TAG synthesised is either stored in discrete cytoplasmic droplets or secreted within VLDL particles. Two DGAT activities are found in microsomes: DGAT I or overt, cytosol-accessible DGAT, which is suggested to catalyse the synthesis of TAG destined for cytoplasmic droplets; and DGAT II, accessible to its substrates from the lumenal aspect of the endoplasmic reticular membrane 1 and thought to catalyse the synthesis of TAG on the lumenal aspect, from where it is incorporated into VLDL during the two-step process of particle lipidation. Experimental evidence for the incorporation and transfer of DAG and acyl moieites across the membrane for use by DGAT II was subsequently provided in Abo-Hashema et al. 2 Consequently, the relative activities of the two DGATs may have a significant impact upon the level of triglyceridaemia, as well as on the development of steatosis. More recently, the cDNAs of genes coding for two separate DGATs have been cloned and sequenced. 3, 4 In the present study, the activities of both DGATs I and II in lean Ob=?, and ob=ob null mice, which have steatotic livers and are hypertriglyceridaemic, 5, 6 were investigated in order to study whether the relative activities of the two DGATs are affected by the altered hepatic metabolic profile of these animals.
Methods
Lean Ob=? (n ¼ 3) and C57BL=6O1a ob=ob (n ¼ 5) female mice obtained from Harlan (UK) were maintained on standard laboratory chow (Scientific Dietary Services, UK) and water ad libitum, and under a 12 h light=dark regime at 23 C in accordance with local animal welfare regulations.
Liver microsomes were prepared by differential centrifugation as previously described. 1 Assay of DGAT activity was performed before and after permeabilisation of microsomes by alamethicin in triplicate for each of the wild-type and ob=ob mice, as previously described 1 to yield activities of DGAT I only and combined DGATs I and II, respectively. Protein concentrations were determined as in Bradford 7 using bovine serum albumen as standard, and determination of TAG in chloroform -methanol extracts of liver samples was made using the Infinity Reagent kit (Sigma, Poole, UK).
Both DGAT and TAG determinations were performed in triplicate for each of the wild-type and ob=ob mice. Palmitoyl-1-14 C Coenzyme A (60 mCi=mmol) was purchased from NEN Life Science Products (UK). All other chemicals were obtained from Sigma (Poole, UK) and were of the highest grade available. Statistical comparisons were made using Student's t-test.
Results and discussion
Total hepatic TAG concentrations of ob=ob mice were significantly elevated when compared to lean Ob=? (Figure 1) as expected. 5, 6 This is analogous to the effect observed in obese subjects, which show elevated hepatic TAG content and a high degree of steatosis. 8, 9 There was a concomitant increase in the activities of both DGATs by very similar factors (2.5-fold, see Figure 2 ) such that the ratio of DGAT II to DGAT I activity remained constant. This level of increase in the overall activity of liver DGAT is much higher than that previously reported for obese (fa=fa) Zucker rats. 10 In that study no distinction was made between the two DGAT activities subsequently identified; 1 further, work in our laboratory has shown that DGAT activities are susceptible to inhibition by detergent (unpublished data) and this may account for the lower overall DGAT activities observed in Jamdar and Cao. 10 The reduction of leptin, and associated hyperphagia in ob=ob mice would result in increased availability of fatty acids and diacylglycerols for utilisation by DGAT, and in response hepatic DGAT activities increase (see Figure 2) . We suggest the increased rate of hepatic TAG secretion and intracellular accumulation of TAG in ob=ob mice, paralleled by increases in DGAT I and II activities could lead to the steatosis and hypertriglyceridaemia observed in the ob=ob genotype. 9, 11 Consequently, these data raise the prospect that drugs that are specific to either one or other of the two DGAT activities could affect the balance between the retention of TAG within the liver, and the development of hypertriglyceridaemia, both of which conditions have deleterious consequences, unless accompanied by strategies aimed at increasing either hepatic or peripheral fatty acid oxidation, respectively. Overt and latent DGAT in ob=ob mouse liver IJ Waterman and VA Zammit
